Truist Financial Corp Sells 763 Shares of Balchem Co. (NASDAQ:BCPC)

Truist Financial Corp lowered its position in shares of Balchem Co. (NASDAQ:BCPC) by 11.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,973 shares of the basic materials company’s stock after selling 763 shares during the period. Truist Financial Corp’s holdings in Balchem were worth $974,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Westside Investment Management Inc. bought a new stake in shares of Balchem during the third quarter valued at approximately $27,000. R Squared Ltd bought a new stake in Balchem in the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB bought a new stake in Balchem in the 3rd quarter worth approximately $35,000. Pacer Advisors Inc. grew its position in Balchem by 18.4% in the 4th quarter. Pacer Advisors Inc. now owns 1,113 shares of the basic materials company’s stock worth $181,000 after purchasing an additional 173 shares during the period. Finally, Independent Solutions Wealth Management LLC bought a new stake in Balchem in the 3rd quarter worth approximately $203,000. Institutional investors own 87.91% of the company’s stock.

Analyst Ratings Changes

BCPC has been the subject of a number of research analyst reports. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. HC Wainwright reaffirmed a “buy” rating and issued a $190.00 target price on shares of Balchem in a research report on Monday, February 24th. Finally, Sidoti raised shares of Balchem to a “hold” rating in a research report on Tuesday, February 25th.

Balchem Trading Up 1.2 %

Shares of Balchem stock opened at $174.03 on Friday. The company’s fifty day simple moving average is $162.41 and its 200-day simple moving average is $169.56. The stock has a market capitalization of $5.66 billion, a PE ratio of 44.28, a P/E/G ratio of 4.41 and a beta of 0.69. Balchem Co. has a 1-year low of $137.69 and a 1-year high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16.

Balchem (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. As a group, equities analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current year.

Balchem Increases Dividend

The firm also recently declared an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. This represents a dividend yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. Balchem’s dividend payout ratio (DPR) is currently 22.14%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.